174 related articles for article (PubMed ID: 35994860)
1. The role of interleukin-17 in epilepsy.
An J; Li H; Xia D; Xu B; Wang J; Qiu H; He J
Epilepsy Res; 2022 Oct; 186():107001. PubMed ID: 35994860
[TBL] [Abstract][Full Text] [Related]
2. Brain region and epilepsy-associated differences in inflammatory mediator levels in medically refractory mesial temporal lobe epilepsy.
Strauss KI; Elisevich KV
J Neuroinflammation; 2016 Oct; 13(1):270. PubMed ID: 27737716
[TBL] [Abstract][Full Text] [Related]
3. Microglia in epilepsy.
Yu C; Deng XJ; Xu D
Neurobiol Dis; 2023 Sep; 185():106249. PubMed ID: 37536386
[TBL] [Abstract][Full Text] [Related]
4. Altered Expression of Intersectin1-L in Patients with Refractory Epilepsy and in Experimental Epileptic Rats.
Yang X; Xu X; Zhang Y; Wang S; Li M; Wang X
Cell Mol Neurobiol; 2015 Aug; 35(6):871-80. PubMed ID: 25783631
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Neuroglial Apoptosis and Neuroinflammation in the Epileptic Focus of the Brain and in the Blood of Patients with Drug-Resistant Epilepsy.
Sokolova TV; Zabrodskaya YM; Litovchenko AV; Paramonova NM; Kasumov VR; Kravtsova SV; Skiteva EN; Sitovskaya DA; Bazhanova ED
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293411
[TBL] [Abstract][Full Text] [Related]
6. The role of inflammation in the development of epilepsy.
Rana A; Musto AE
J Neuroinflammation; 2018 May; 15(1):144. PubMed ID: 29764485
[TBL] [Abstract][Full Text] [Related]
7. Innate and adaptive immunity in human epilepsies.
Bauer J; Becker AJ; Elyaman W; Peltola J; Rüegg S; Titulaer MJ; Varley JA; Beghi E
Epilepsia; 2017 Jul; 58 Suppl 3(Suppl Suppl 3):57-68. PubMed ID: 28675562
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological modulation of cytokines correlating neuroinflammatory cascades in epileptogenesis.
Vishwakarma S; Singh S; Singh TG
Mol Biol Rep; 2022 Feb; 49(2):1437-1452. PubMed ID: 34751915
[TBL] [Abstract][Full Text] [Related]
9. Review: Animal models of acquired epilepsy: insights into mechanisms of human epileptogenesis.
Becker AJ
Neuropathol Appl Neurobiol; 2018 Feb; 44(1):112-129. PubMed ID: 29130506
[TBL] [Abstract][Full Text] [Related]
10. Inflammation in pediatric epilepsies: Update on clinical features and treatment options.
Granata T; Fusco L; Matricardi S; Tozzo A; Janigro D; Nabbout R
Epilepsy Behav; 2022 Jun; 131(Pt B):107959. PubMed ID: 33867302
[TBL] [Abstract][Full Text] [Related]
11. Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approaches.
Vitaliti G; Pavone P; Mahmood F; Nunnari G; Falsaperla R
Hum Vaccin Immunother; 2014; 10(4):868-75. PubMed ID: 24609096
[TBL] [Abstract][Full Text] [Related]
12. Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.
Dey A; Kang X; Qiu J; Du Y; Jiang J
Trends Pharmacol Sci; 2016 Jun; 37(6):463-484. PubMed ID: 27062228
[TBL] [Abstract][Full Text] [Related]
13. Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy.
Yamanaka G; Ishida Y; Kanou K; Suzuki S; Watanabe Y; Takamatsu T; Morichi S; Go S; Oana S; Yamazaki T; Kawashima H
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208064
[TBL] [Abstract][Full Text] [Related]
14. Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy.
Xu D; Robinson AP; Ishii T; Duncan DS; Alden TD; Goings GE; Ifergan I; Podojil JR; Penaloza-MacMaster P; Kearney JA; Swanson GT; Miller SD; Koh S
J Exp Med; 2018 Apr; 215(4):1169-1186. PubMed ID: 29487082
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms.
Alyu F; Dikmen M
Acta Neuropsychiatr; 2017 Feb; 29(1):1-16. PubMed ID: 27692004
[TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation and Proinflammatory Cytokines in Epileptogenesis.
Soltani Khaboushan A; Yazdanpanah N; Rezaei N
Mol Neurobiol; 2022 Mar; 59(3):1724-1743. PubMed ID: 35015252
[TBL] [Abstract][Full Text] [Related]
17. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy.
Ravizza T; Gagliardi B; Noé F; Boer K; Aronica E; Vezzani A
Neurobiol Dis; 2008 Jan; 29(1):142-60. PubMed ID: 17931873
[TBL] [Abstract][Full Text] [Related]
18. Immunological perspectives of temporal lobe seizures.
Liimatainen S; Lehtimäki K; Palmio J; Alapirtti T; Peltola J
J Neuroimmunol; 2013 Oct; 263(1-2):1-7. PubMed ID: 23998423
[TBL] [Abstract][Full Text] [Related]
19. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
Rossini L; Villani F; Granata T; Tassi L; Tringali G; Cardinale F; Aronica E; Spreafico R; Garbelli R
Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425
[TBL] [Abstract][Full Text] [Related]
20. The Potential Role of Pro-Inflammatory and Anti-Inflammatory Cytokines in Epilepsy Pathogenesis.
Kamali AN; Zian Z; Bautista JM; Hamedifar H; Hossein-Khannazer N; Hosseinzadeh R; Yazdani R; Azizi G
Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1760-1774. PubMed ID: 33200702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
